Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Fluvastatin is effective against thymic carcinoma.

Hayashi K, Nakazato Y, Morito N, Sagi M, Fujita T, Anzai N, Chida M.

Life Sci. 2019 Nov 28;240:117110. doi: 10.1016/j.lfs.2019.117110. [Epub ahead of print]

PMID:
31786191
2.

Initial perfusate purification during subnormothermic machine perfusion for porcine liver donated after cardiac death.

Obara H, Morito N, Matsuno N, Yoshikawa R, Nakajo T, Gochi M, Otani M, Shonaka T, Furukawa H, Hirano T, Enosawa S.

J Artif Organs. 2019 Aug 7. doi: 10.1007/s10047-019-01123-5. [Epub ahead of print]

PMID:
31392524
3.

Plasma Exchange Is Highly Effective for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patients With Rapidly Progressive Glomerulonephritis Who Have Advanced to Dialysis Dependence: A Single-Center Case Series.

Nishida R, Kaneko S, Usui J, Kawamura T, Tsunoda R, Tawara T, Fujita A, Nagai K, Kai H, Morito N, Saito C, Yamagata K.

Ther Apher Dial. 2019 Jun;23(3):253-260. doi: 10.1111/1744-9987.12830.

PMID:
31033151
4.

Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.

Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators.

Heart Vessels. 2019 Apr 10. doi: 10.1007/s00380-019-01374-5. [Epub ahead of print]

PMID:
30972549
5.

Evaluation Using an Isolated Reperfusion Model for Porcine Liver Donated After Cardiac Death Preserved with Oxygenated Hypothermic Machine Perfusion.

Yoshikawa R, Matsuno N, Morito N, Gouchi M, Otani M, Takahashi H, Shonaka T, Nishikawa Y, Enosawa S, Hirano T, Furukawa H, Obara H.

Ann Transplant. 2018 Nov 27;23:822-827. doi: 10.12659/AOT.910008.

6.

Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.

Imaizumi S, Shiga Y, Ogawa M, Sako H, Nagata Y, Matsunaga A, Shirotani T, Hoshino F, Yahiro E, Uehara Y, Morito N, Tanigawa H, Shimono D, Fukushima M, Sugihara H, Norimatsu K, Kusumoto T, Saku K, Miura SI; ACADEMIE Study Investigators.

Heart Vessels. 2019 Apr;34(4):698-710. doi: 10.1007/s00380-018-1286-2. Epub 2018 Nov 8. Erratum in: Heart Vessels. 2019 Apr 10;:.

PMID:
30406819
7.

Optimum Perfusate Volume of Purified Subnormothermic Machine Perfusion for Porcine Liver Donated After Cardiac Death.

Obara H, Morito N, Matsuno N, Yoshikawa R, Gouchi M, Otani M, Shonaka T, Takahashi H, Enosawa S, Hirano T, Furukawa H.

Transplant Proc. 2018 Nov;50(9):2830-2833. doi: 10.1016/j.transproceed.2018.03.055. Epub 2018 Mar 15.

PMID:
30401406
8.

Ex Vivo Reperfusion Model to Evaluate Utility of Machine Preservation for Porcine Liver Donated After Cardiac Death.

Yoshikawa R, Obara H, Matsuno N, Morito N, Gouchi M, Otani M, Shonaka T, Takahashi H, Enosawa S, Hirano T, Furukawa H.

Transplant Proc. 2018 Nov;50(9):2826-2829. doi: 10.1016/j.transproceed.2018.04.020. Epub 2018 Apr 11.

PMID:
30401405
9.

Mice harboring an MCTO mutation exhibit renal failure resembling nephropathy in human patients.

Tsunakawa Y, Hamada M, Matsunaga Y, Fuseya S, Jeon H, Wakimoto Y, Usui T, Kanai M, Mizuno S, Morito N, Takahashi S.

Exp Anim. 2019 Feb 26;68(1):103-111. doi: 10.1538/expanim.18-0093. Epub 2018 Oct 26.

10.

Long-term Body Weight Gain After Maturity is Associated With the Incidence of Chronic Kidney Disease (CKD), Independent of Current Body Weight, in Middle-aged and Older Men.

Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y.

J Epidemiol. 2019 Jun 5;29(6):213-219. doi: 10.2188/jea.JE20170304. Epub 2018 Oct 20.

11.

Recommendations of Lifestyle Modification According to a Survey of First-Year University Students.

Nakanishi J, Suematsu Y, Arimura T, Kuwano T, Shiga Y, Kitajima K, Morito N, Nii T, Saku K, Miura SI.

J Clin Med Res. 2018 Oct;10(10):772-780. doi: 10.14740/jocmr3574w. Epub 2018 Sep 10.

12.

Oxygen consumption during hypothermic and subnormothermic machine perfusions of porcine liver grafts after cardiac death.

Morito N, Obara H, Matsuno N, Enosawa S, Furukawa H.

J Artif Organs. 2018 Dec;21(4):450-457. doi: 10.1007/s10047-018-1063-0. Epub 2018 Jul 25.

PMID:
30046934
13.

A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome.

Sato Y, Tsukaguchi H, Morita H, Higasa K, Tran MTN, Hamada M, Usui T, Morito N, Horita S, Hayashi T, Takagi J, Yamaguchi I, Nguyen HT, Harada M, Inui K, Maruta Y, Inoue Y, Koiwa F, Sato H, Matsuda F, Ayabe S, Mizuno S, Sugiyama F, Takahashi S, Yoshimura A.

Kidney Int. 2018 Aug;94(2):396-407. doi: 10.1016/j.kint.2018.02.025. Epub 2018 May 18.

PMID:
29779709
14.

The Current Conditions and Lifestyles of Obese University Students.

Morito N, Suematsu Y, Koyoshi R, Shiga Y, Kuwano T, Iwata A, Fujimi K, Kawamura A, Miura SI.

J Clin Med Res. 2018 Mar;10(3):240-246. doi: 10.14740/jocmr3329w. Epub 2018 Jan 26.

15.

Associations between microalbuminuria and parameters of flow-mediated vasodilatation obtained by continuous measurement approaches.

Koyoshi R, Hitaka-Yoshimine Y, Shiga Y, Kuwano T, Sugihara M, Ike A, Iwata A, Sako H, Morito N, Kawamura A, Miura SI.

Clin Exp Hypertens. 2018;40(8):715-720. doi: 10.1080/10641963.2018.1425422. Epub 2018 Jan 19.

PMID:
29351006
16.

Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.

Kawamura T, Usui J, Kaneko S, Tsunoda R, Imai E, Kai H, Morito N, Saito C, Nagata M, Yamagata K.

BMC Nephrol. 2017 Nov 25;18(1):337. doi: 10.1186/s12882-017-0754-8.

17.

The joint impact of habitual exercise and glycemic control on the incidence of chronic kidney disease (CKD) in middle-aged and older males.

Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y.

Environ Health Prev Med. 2017 Nov 6;22(1):76. doi: 10.1186/s12199-017-0683-y.

18.

Transcription factor MafB may play an important role in secondary hyperparathyroidism.

Morito N, Yoh K, Usui T, Oishi H, Ojima M, Fujita A, Koshida R, Shawki HH, Hamada M, Muratani M, Yamagata K, Takahashi S.

Kidney Int. 2018 Jan;93(1):54-68. doi: 10.1016/j.kint.2017.06.023. Epub 2017 Sep 28.

PMID:
28964572
19.

Effectiveness of Plasmapheresis in a Patient with Anti-glomerular Basement Membrane Antibody Glomerulonephritis with Advanced Kidney Dysfunction.

Usui T, Kai H, Noguchi K, Morito N, Usui J, Saito C, Uesugi N, Nagata M, Yamagata K.

Intern Med. 2017 Sep 15;56(18):2475-2479. doi: 10.2169/internalmedicine.8571-16. Epub 2017 Aug 21.

20.

Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males.

Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y.

Clin Exp Hypertens. 2017;39(7):645-654. doi: 10.1080/10641963.2017.1306541. Epub 2017 Jun 7.

PMID:
28590145
21.

Two autosomal dominant polycystic kidney (ADPKD) cases with advanced renal dysfunction, effectively treated with tolvaptan.

Kai H, Shinozaki Y, Nishikubo A, Watanabe M, Tawara T, Iwase M, Tsunoda R, Moriyama N, Usui T, Kawamura T, Nagai K, Hagiwara M, Saito C, Morito N, Usui J, Yamagata K.

CEN Case Rep. 2016 May;5(1):87-90. doi: 10.1007/s13730-015-0198-6. Epub 2015 Nov 17.

22.

Effects of Tolvaptan With or Without the Pre-Administration of Renin-Angiotensin System Blockers in Hospitalized Patients With Acute Decompensated Heart Failure.

Adachi S, Miura SI, Shiga Y, Arimura T, Morii J, Kuwano T, Kitajima K, Iwata A, Morito N, Fujimi K, Yahiro E, Nishikawa H, Saku K.

Int Heart J. 2017 May 31;58(3):385-392. doi: 10.1536/ihj.16-220. Epub 2017 May 8.

23.

The association between changes in lifestyle behaviors and the incidence of chronic kidney disease (CKD) in middle-aged and older men.

Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y.

J Epidemiol. 2017 Aug;27(8):389-397. doi: 10.1016/j.je.2016.08.013. Epub 2017 Apr 3.

24.

The Change in Body Weight During Hospitalization Predicts Mortality in Patients With Acute Decompensated Heart Failure.

Komaki T, Miura SI, Arimura T, Shiga Y, Morii J, Kuwano T, Imaizumi S, Kitajima K, Iwata A, Morito N, Yahiro E, Fujimi K, Matsunaga A, Saku K.

J Clin Med Res. 2017 Mar;9(3):200-206. doi: 10.14740/jocmr2890w. Epub 2017 Jan 25.

25.

Depressor and Anti-Inflammatory Effects of Angiotensin II Receptor Blockers in Metabolic and/or Hypertensive Patients With Coronary Artery Disease: A Randomized, Prospective Study (DIAMOND Study).

Adachi S, Miura S, Shiga Y, Arimura T, Kuwano T, Kitajima K, Ike A, Sugihara M, Iwata A, Nishikawa H, Morito N, Saku K.

J Clin Med Res. 2016 Oct;8(10):743-8. doi: 10.14740/jocmr2675w. Epub 2016 Aug 30.

26.

Associations between parameters of flow-mediated vasodilatation obtained by continuous measurement approaches and the presence of coronary artery disease and the severity of coronary atherosclerosis.

Hitaka Y, Miura S, Koyoshi R, Suematsu Y, Miyase Y, Norimatsu K, Adachi S, Shiga Y, Morito N, Nishikawa H, Saku K.

Clin Exp Hypertens. 2016;38(5):443-50. doi: 10.3109/10641963.2016.1163365. Epub 2016 Jun 30.

PMID:
27359079
27.

Regulated Oxygenation of Rewarming Machine Perfusion for Porcine Donation After Cardiac Death Liver Transplantation.

Morito N, Obara H, Matsuno N, Enosawa S, Watanabe K, Furukori M, Furukawa H.

Transplant Proc. 2016 May;48(4):1244-6. doi: 10.1016/j.transproceed.2015.12.098.

PMID:
27320596
28.

The Association Between Unhealthy Lifestyle Behaviors and the Prevalence of Chronic Kidney Disease (CKD) in Middle-Aged and Older Men.

Michishita R, Matsuda T, Kawakami S, Kiyonaga A, Tanaka H, Morito N, Higaki Y.

J Epidemiol. 2016 Jul 5;26(7):378-85. doi: 10.2188/jea.JE20150202. Epub 2016 Mar 5.

29.

The accumulation of healthy lifestyle behaviors prevents the incidence of chronic kidney disease (CKD) in middle-aged and older males.

Michishita R, Matsuda T, Kawakami S, Kiyonaga A, Tanaka H, Morito N, Higaki Y.

Environ Health Prev Med. 2016 May;21(3):129-37. doi: 10.1007/s12199-016-0506-6. Epub 2016 Jan 21.

30.

Recent Patient Characteristics and Medications at Admission and Discharge in Hospitalized Patients With Heart Failure.

Arimura T, Miura S, Morito N, Shiga Y, Kitajima K, Morii J, Iwata A, Fujimi K, Yahiro E, Saku K.

J Clin Med Res. 2016 Feb;8(2):97-104. doi: 10.14740/jocmr2402w. Epub 2015 Dec 28.

31.

Association Between a Ban on Smoking in a Hospital and the In-Hospital Onset of Acute Myocardial Infarction.

Morito N, Miura SI, Yano M, Hitaka Y, Nishikawa H, Saku K.

Cardiol Res. 2015 Jun;6(3):278-282. doi: 10.14740/cr404e. Epub 2015 Jun 11.

32.

Overexpression of GATA-3 in T cells accelerates dextran sulfate sodium-induced colitis.

Okamura M, Yoh K, Ojima M, Morito N, Takahashi S.

Exp Anim. 2014;63(2):133-40.

33.

Overexpression of Mafb in podocytes protects against diabetic nephropathy.

Morito N, Yoh K, Ojima M, Okamura M, Nakamura M, Hamada M, Shimohata H, Moriguchi T, Yamagata K, Takahashi S.

J Am Soc Nephrol. 2014 Nov;25(11):2546-57. doi: 10.1681/ASN.2013090993. Epub 2014 Apr 10.

34.

GATA2 regulates body water homeostasis through maintaining aquaporin 2 expression in renal collecting ducts.

Yu L, Moriguchi T, Souma T, Takai J, Satoh H, Morito N, Engel JD, Yamamoto M.

Mol Cell Biol. 2014 Jun;34(11):1929-41. doi: 10.1128/MCB.01659-13. Epub 2014 Mar 17.

35.

O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor.

Kihara M, Ito K, Nakata J, Otani M, Tran NL, Morito N, Takahashi S, Wada Y, Izui S.

J Am Soc Nephrol. 2014 Jun;25(6):1282-90. doi: 10.1681/ASN.2013070771. Epub 2014 Feb 7.

36.

Health-related quality of life and prognosis in patients with chronic kidney disease: a 3-year follow-up study.

Okubo R, Kai H, Kondo M, Saito C, Yoh K, Morito N, Usui J, Yamagata K.

Clin Exp Nephrol. 2014 Oct;18(5):697-703. doi: 10.1007/s10157-013-0901-x. Epub 2013 Nov 6.

PMID:
24198050
37.

Effects of irbesartan on inflammatory cytokine concentrations in patients with chronic glomerulonephritis.

Tsuruoka S, Kai H, Usui J, Morito N, Saito C, Yoh K, Yamagata K.

Intern Med. 2013;52(3):303-8. Epub 2013 Feb 1.

38.

Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice.

Okada K, Ma D, Warabi E, Morito N, Akiyama K, Murata Y, Yamagata K, Bukawa H, Shoda J, Ishii T, Yanagawa T.

Cancer Chemother Pharmacol. 2013 Feb;71(2):503-9. doi: 10.1007/s00280-012-2046-0. Epub 2012 Dec 11.

PMID:
23228991
39.

Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.

Harada N, Ito K, Hosoya T, Mimura J, Maruyama A, Noguchi N, Yagami K, Morito N, Takahashi S, Maher JM, Yamamoto M, Itoh K.

Free Radic Biol Med. 2012 Dec 15;53(12):2256-62. doi: 10.1016/j.freeradbiomed.2012.10.001. Epub 2012 Oct 7.

PMID:
23051009
40.

Overexpression of RORγt under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice.

Yoh K, Morito N, Ojima M, Shibuya K, Yamashita Y, Morishima Y, Ishii Y, Kusakabe M, Nishikii H, Fujita A, Matsunaga E, Okamura M, Hamada M, Suto A, Nakajima H, Shibuya A, Yamagata K, Takahashi S.

Eur J Immunol. 2012 Aug;42(8):1999-2009. doi: 10.1002/eji.201142250. Epub 2012 Jul 9.

42.

A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion.

Nagai K, Usui J, Noguchi K, Unai K, Hiwatashi A, Arakawa Y, Togashi A, Morito N, Saito C, Yoh K, Tsuruoka S, Kojima H, Aita K, Nagata M, Yamagata K.

Pathol Int. 2011 Nov;61(11):686-90. doi: 10.1111/j.1440-1827.2011.02727.x. Epub 2011 Oct 21.

PMID:
22029682
43.

A novel transgenic mouse model of the human multiple myeloma chromosomal translocation t(14;16)(q32;q23).

Morito N, Yoh K, Maeda A, Nakano T, Fujita A, Kusakabe M, Hamada M, Kudo T, Yamagata K, Takahashi S.

Cancer Res. 2011 Jan 15;71(2):339-48. doi: 10.1158/0008-5472.CAN-10-1057. Epub 2011 Jan 11.

44.

Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection.

Sakai K, Morito N, Usui J, Hagiwara M, Hiwatashi A, Fukuda K, Nanmoku T, Toda T, Matsui N, Nagata M, Yamagata K.

Nephrol Dial Transplant. 2011 Jan;26(1):371-3. doi: 10.1093/ndt/gfq600. Epub 2010 Oct 19.

PMID:
20959346
45.

Role of endogenous retroviruses in murine SLE.

Baudino L, Yoshinobu K, Morito N, Santiago-Raber ML, Izui S.

Autoimmun Rev. 2010 Nov;10(1):27-34. doi: 10.1016/j.autrev.2010.07.012. Epub 2010 Jul 24. Review.

PMID:
20659589
46.

MafA-deficient and beta cell-specific MafK-overexpressing hybrid transgenic mice develop human-like severe diabetic nephropathy.

Shimohata H, Yoh K, Fujita A, Morito N, Ojima M, Tanaka H, Hirayama K, Kobayashi M, Kudo T, Yamagata K, Takahashi S.

Biochem Biophys Res Commun. 2009 Nov 13;389(2):235-40. doi: 10.1016/j.bbrc.2009.08.124. Epub 2009 Aug 26.

PMID:
19715672
47.

Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice.

Yoshinobu K, Baudino L, Santiago-Raber ML, Morito N, Dunand-Sauthier I, Morley BJ, Evans LH, Izui S.

J Immunol. 2009 Jun 15;182(12):8094-103. doi: 10.4049/jimmunol.0900263.

48.

Overexpression of T-bet in T cells accelerates autoimmune glomerulonephritis in mice with a dominant Th1 background.

Shimohata H, Yamada A, Yoh K, Ishizaki K, Morito N, Yamagata K, Takahashi S.

J Nephrol. 2009 Jan-Feb;22(1):123-9.

PMID:
19229827
49.

Secondary membranous glomerulonephritis associated with recipient residual lymphoma cells after allogeneic bone marrow transplantation.

Sakai K, Usui J, Kai H, Hagiwara M, Morito N, Saito C, Yoh K, Tsuruoka S, Hirayama K, Aita K, Nagata M, Yamagata K.

Clin Exp Nephrol. 2009 Apr;13(2):174-178. doi: 10.1007/s10157-008-0120-z. Epub 2008 Dec 26.

PMID:
19110655
50.

Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.

Yoh K, Hirayama A, Ishizaki K, Yamada A, Takeuchi M, Yamagishi S, Morito N, Nakano T, Ojima M, Shimohata H, Itoh K, Takahashi S, Yamamoto M.

Genes Cells. 2008 Nov;13(11):1159-70. doi: 10.1111/j.1365-2443.2008.01234.x.

Supplemental Content

Loading ...
Support Center